Global Bowel Management Systems Market to Reach Approximately USD 1.8 Billion by 2027, Estimates DelveInsight

Global Bowel Management systems market growth is primarily attributed to the increasing geriatric population across the globe who are more susceptible to developing bowel-associated disorders. Also, rising neurological disorders such as Parkinson’s disease, stroke, growing cases of nerve injuries due to spinal cord injuries, and trauma injuries, among others, would also increase the demand for Bowel Management systems.

New Delhi, INDIA


Las Vegas, USA, June 23, 2022 (GLOBE NEWSWIRE) -- Global Bowel Management Systems Market to Reach Approximately USD 1.8 Billion by 2027, Estimates DelveInsight

Global Bowel Management systems market growth is primarily attributed to the increasing geriatric population across the globe who are more susceptible to developing bowel-associated disorders. Also, rising neurological disorders such as Parkinson’s disease, stroke, growing cases of nerve injuries due to spinal cord injuries, and trauma injuries, among others, would also increase the demand for Bowel Management systems.

DelveInsight's Bowel Management Systems Market Insights and Forecast report provides the current and forecast Bowel Management Systems, upcoming innovations in the devices, individual market shares of the devices, challenges, drivers, and barriers, market trends, and key competitors in the Bowel Management Systems Market scenario.

Some of the salient features of the Bowel Management Systems Market report: 

  • According to DelveInsight analysis, North America is expected to dominate the overall Bowel Management Systems Market during the forecasted period.
  • Key Bowel Management Systems companies proactively working in the market include Coloplast Corp, Medtronic, B. Braun Melsungen AG, Becton, Dickinson and Company, ConvaTec Inc., Laborie., Consure Medical, Axonics, Inc., Renew Medical Inc, Hollister Incorporated, Welland Medical Limited., Wellspect HealthCare (Dentsply Sirona Company) Restech., Bioness, Inc., A.M.I. GmbH, ProSys International Ltd, Angiplast Pvt Ltd., and Marlen Manufacturing & Development Company, among others.
  • As per DelveInsight estimates, the Global Bowel Management Systems Market size was valued at USD 1.48 billion in 2021, growing at a CAGR of 3.98% during the forecast period from 2022 to 2027, in order to reach USD 1.87 billion by 2027.
  • In October 2021, Laborie Medical Technologies Corp. (Laborie) a specialist medical technology company, acquired Pelvalon, Inc., a privately-held medical device company located in Redwood City, CA which has developed an innovative product called the Eclipse™ System, a non-surgical, patient-controlled device for women suffering from fecal incontinence (FI).
  • In May 2021, Axonics, Inc., a global medical technology company focused on developing and commercializing novel products for the treatment of bladder and bowel dysfunction, received European CE Mark approval for its second-generation Axonics r-SNM® implantable neurostimulator (INS) and wireless patient remote control with SmartMRI™ technology.
  • In August 2020, Medtronic plc received approval from the US FDA for its InterStim™ Micro neurostimulator and InterStim™ SureScan™ MRI leads used for treating overactive bladder (OAB), fecal incontinence (FI), and non-obstructive urinary retention.
  • On November 22, 2019, Dentsply Sirona received FDA approval for Navina Smart System and Navina Classic System intended for use in patients with neurogenic bowel dysfunction, fecal incontinence, and chronic constipation.

To know the key highlights related download  Bowel Management Systems Market Sample Report

Bowel Management Systems Overview 

Bowel incontinence, also known as fecal incontinence is generally the situation when the patient is not able to control bowel movements which results in involuntary loss of solid or liquid stool. The clinical devices used to manage bowel activity are called Bowel Management systems.

Bowel Management Systems Market Insight

Geographically, the Global Eyewear market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. In terms of revenue share, North America is expected to occupy a major share in the overall Bowel Management Systems market and is expected to hold its position during the forecasted period. This domination is due to the rise in the target population in the region. In addition, an increase in neurological conditions, the presence of leading bowel management systems companies, and favorable reimbursement policies, among others are expected to surge the demand for the bowel management systems market.

Moreover, product approvals in the region for the treatment of bowel discomfort are also expected to bolster the demand for bowel management systems in the country. For instance, on September 06, 2019, Axonics Modulation Technologies, Inc. received FDA clearance for its Axonics Sacral Neuromodulation System indicated for the treatment of chronic fecal incontinence in patients who have failed or are not candidates for other treatments, such as medications or physical therapy.

Learn more about the Key companies covered in the report by downloading  @ Bowel Management Systems Market Assessment

Bowel Management Systems Market Dynamics 

A stellar growth is anticipated for the Bowel Management Systems market owing to several factors such as the increasing geriatric population across the globe who are more susceptible to developing bowel-associated disorders, rising neurological disorders such as Parkinson’s disease, stroke, among others. In addition to that, growing cases of nerve injuries due to spinal cord injuries, trauma injuries, and others would also increase the demand for bowel management systems as these factors most often lead to bowel incontinences. Also, rising government initiatives to raise awareness regarding the prevention and management of bowel control issues, and the launch of various bowel management products, among others are anticipated to bolster the Bowel Management Systems market during the forecasted period. Moreover, recent and new potential approvals of bowel management products would also augment the market for bowel management systems in the forthcoming years. Thus, all the aforementioned factors are expected to propel the bowel management systems market.

However, on the contrary, the discomfort associated with the use of bowel management systems is likely to impede the market for bowel management systems. With the unprecedented COVID-19 pandemic the demand for Bowel Management Systems products in the market decreased. This was due to the temporary suspension of numerous elective procedures and outpatient visits as the healthcare system guidelines worldwide temporarily focused all their efforts on the management of COVID-19 patient load during the initial lockdown period serving as several setbacks in the growth of the r Bowel Management Systems market.

To gain a better understanding of the COVID-19 impact on the Bowel Management Systems Industry, get a snapshot of the Bowel Management Systems Market Impact by COVID-19

Scope of the Bowel Management Systems Market Report

  • Coverage: Global
  • Study Period: 2021-2027
  • Bowel Management Systems Market Segmentation By Product: Devices [Irrigation Systems, Nerve Modulation Devices, Others] Accessories), By Patient Type (Adult And Pediatrics)
  • Bowel Management Systems Market Segmentation By End-User: Hospitals, Ambulatory Surgical Centres, And Home Care
  • Bowel Management Systems Market Segmentation By Geography: North America, Europe, Asia-Pacific, Rest of the World (Middle East, Africa, and South America)
  • Key Bowel Management Systems Companies:  Coloplast Corp, Medtronic, B. Braun Melsungen AG, Becton, Dickinson and Company, ConvaTec Inc., Laborie., Consure Medical, Axonics, Inc., Renew Medical Inc, Hollister Incorporated, Welland Medical Limited., Wellspect HealthCare (Dentsply Sirona Company) Restech., Bioness, Inc., A.M.I. GmbH, ProSys International Ltd, Angiplast Pvt Ltd., Marlen Manufacturing & Development Company, among others.
  • Porter’s Five Forces Analysis
  • Product Profiles
  • Case Studies 
  • KOL's Views
  • Analyst's View

Delveinsight Analysis: The global bowel management systems market was valued at USD 1.48 billion in 2021, growing at a CAGR of 3.98% during the forecast period from 2022 to 2027, in order to reach USD 1.87 billion by 2027.

Know more about which MedTech player is set to dominate the Bowel Management Systems market @ Key Bowel Management Systems Companies 

Table of Contents 

1 Report Introduction
2 Executive summary
3 Regulatory and Patent Analysis
4 Bowel Management Systems Market Key Factors Analysis
5 Bowel Management Systems Market Porter’s Five Forces Analysis
6 COVID-19 Impact Analysis on Bowel Management Systems Market
7 Bowel Management Systems Market Layout
8 Bowel Management Systems Market Global Company Share Analysis – Key 3-5 Companies
9 Bowel Management Systems Company and Product Profiles
10 Project Approach
11 KOL Views
12 DelveInsight Capabilities
13 Disclaimer
14 About DelveInsight

Gain rich insights about the latest Bowel Management Systems regulatory approvals  @ Bowel Management Systems Regulatory Landscape And Patent Analysis

Related Reports

Inflammatory Bowel Disease Market 

DelveInsight's "Inflammatory Bowel Disease Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the Inflammatory bowel disease, historical and forecasted epidemiology as well as the Inflammatory bowel disease market trends, drivers and barriers, and key Inflammatory bowel disease companies like CinRx Pharma, Rottapharm, SK biopharmaceuticals, Synthetic Biologics, Biomica, and many others.

Short Bowel Syndrome Market

DelveInsight's "Short Bowel Syndrome Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the Short Bowel Syndrome, historical and forecasted epidemiology as well as the Short Bowel Syndrome market trends, drivers and barriers, and key Short Bowel Syndrome companies like Takeda, Zealand Pharma, VectivBio AG, 9 Meters Biopharma, and many others.

Ulcerative Colitis Pipeline

DelveInsight’s, “Ulcerative Colitis Pipeline Insight, 2022,” report provides comprehensive insights about 110+ companies and 110+ pipeline drugs in Ulcerative Colitis (UC) pipeline landscape which includes companies like AbbVie, Celgene, Eli Lilly and Company, Lipid Therapeutics, Hoffmann-La Roche, Arena Pharmaceuticals, Theravance Biopharma, Boehringer Ingelheim, Janssen Research & Development, PurGenesis Technologies, Protagonist Therapeutics, Pfizer, and several others.

Irritable Bowel Syndrome Pipeline 

DelveInsight’s, “Irritable Bowel Syndrome Pipeline Insight, 20222,” report provides comprehensive insights about 24+ companies and 24+ pipeline drugs in the Irritable Bowel Syndrome (IBS) pipeline landscape including key companies like Boston Pharmaceuticals, RedHill Biopharma Limited, Takeda, Cosmo Technologies, CinRx Pharma, Rottapharm, SK biopharmaceuticals, Synthetic Biologics, Biomica, and various others.

Crohn’s Disease Pipeline

DelveInsight’s, “Crohn’s Disease Pipeline Insight, 2022,” report provides comprehensive insights about 90+ companies and 90+ pipeline drugs in Crohn’s Disease pipeline landscape, which includes key companies like Amgen, Pfizer, Hoffmann-La Roche, Gilead Sciences, Eli Lilly and Company, Celgene, AstraZeneca, Abbvie, Mesoblast, and many others.

Chronic Pancreatitis Market

DelveInsight’s ‘Chronic pancreatitis Market Insights, Epidemiology and Market Forecast 2032' report delivers an in-depth understanding of the disease, current treatment practice/algorithm, market drivers, market barriers, unmet needs, and key companies involved like Aptalis Pharma, Digestive Care Inc, Kangen Pharmaceuticals, AzurRx BioPharma, and several others.

Ascites Market

DelveInsight’s ‘Ascites Market Insights, Epidemiology, and Market Forecast 2032’ report delivers an in-depth understanding of the Ascites, current treatment practice/algorithm, market drivers, market barriers, unmet needs, and key companies involved like BioVie, Noorik Biopharmaceuticals AG, and others.

Chronic Venous Ulceration Market

DelveInsight’s ‘Chronic Venous Ulceration Market Insights, Epidemiology and Market Forecast 2032’ report delivers an in-depth understanding of the CVU, historical and forecasted epidemiology, market drivers, market barriers, and key companies involved like Merck, Bristol-Myers Squibb, Eli Lilly, Taiho Oncology, Hutchison Medipharma Ltd, G1 Therapeutics, Isofol Medical, AB Science, Seagen, Effector Therapeutics, and many more.

Ulcerative Proctitis Pipeline

DelveInsight’s, “Ulcerative Proctitis - Pipeline Insight, 2022,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in the Ulcerative Proctitis pipeline landscape, which includes companies like First Wave Bio, Dr Falk Pharma, Alfasigma, Cristcot LLC, and several others.

Interested to know more about the breakthrough happenings? Take a look at the posts below

More Trending Reports in Healthcare 

Facial Lines Market | Adult T-Cell Leukemia Market | Shingles Market | Kaposi's Sarcoma Market | Surgical Mask & Respirator Market | Stem Cell Market | Plaque Modification Devices Market | Inflammatory Pain Market | Hepatic Cirrhosis Market | Sly Syndrome Market | Shigellosis  Market | Tuberculosis Market I

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

For more insights, visit Pharma, Healthcare, and Biotech News 

 

Contact Data